Chyi-Liang Chen | Molecular epidemiology | Best Researcher Award

Published on by Academic Awards

Prof. Chyi-Liang Chen | Molecular epidemiology | Best Researcher Award

Prof. Chyi-Liang Chen, Linkou Chang Gung Memorial Hospital Children’s Medical Center, Taiwan

🧬 Prof. Chyi-Liang Chen is an Associate Researcher at Chang Gung Memorial Hospital and the Department of Microbiology and Immunology, Chang Gung University, Taiwan. He earned his BSc, MSc, and PhD in Life Sciences from National Chung Hsing University. With extensive postdoctoral research at Chang Gung University and the University of Calgary, his expertise spans microbiology, molecular microbiology, protein engineering, bacterial genomics, and antimicrobial resistance. He has authored numerous SCIE-indexed publications on bacterial pathogenesis and genetic engineering. His work contributes to biotechnology, genomics, and patent applications, advancing microbial research. πŸ¦ πŸ”¬πŸ“š

Publication Profile

Scopus

Orcid

πŸŽ“ Educational Background

Prof. Chyi-Liang Chen pursued his academic journey in Life Sciences at National Chung Hsing University, Taiwan. He obtained his Bachelor’s degree (1984–1988) from the Department of Life Sciences (formerly the Department of Botany). He then completed his Master’s degree (1988–1990) at the Institute of Life Sciences (previously the Institute of Botany Microbiome). Further advancing his expertise, he earned a Ph.D. (1990–1995) from the same institute. His strong foundation in microbiology, molecular biology, and botany has significantly contributed to his impactful research in bacterial genomics and biotechnology. πŸ§¬πŸ”¬πŸ“–

πŸ… Professional Experience

Prof. Chyi-Liang Chen has an extensive career in microbiology and immunology. He began as a Postdoctoral Fellow at Chang Gung University, Taiwan (1997–1999) before moving to the University of Calgary, Canada (1999–2002). He later returned to Chang Gung University (2002–2006). He served as an Assistant Professor at Yuanzhi University and later as an Assistant Researcher at Chang Gung Memorial Hospital (2006–2012). Since 2012, he has been an Associate Researcher at Chang Gung Memorial Hospital and, from 2022, also at the Department of Microbiology and Immunology, Chang Gung University. πŸ§ͺπŸ”¬πŸ“š

πŸ”¬ Research Focus

Prof. Chyi-Liang Chen specializes in infectious diseases, microbiology, and immunology. His research spans viral infections 🦠, antimicrobial resistance πŸ’Š, and host-pathogen interactions πŸ₯. He has contributed to studies on multiple viral infections in children, cytomegalovirus colitis, and antiviral treatments. His work also explores the gut microbiota’s role in cancer therapy and cross-species microRNAs. Additionally, he has investigated COVID-19 therapeutics 😷 and SARS-CoV-2 variants 🧬. His studies provide crucial insights into infectious disease management, making significant contributions to global health and microbiological research. πŸŒπŸ”

Publication Top Notes

1️⃣ Multiple viral infections and antimicrobial use in hospitalized children with respiratory illness during pandemic and early post-pandemic era, Taiwan πŸ¦ πŸ’Š (Heliyon, 2025)Β 
2️⃣ Identifying the function of novel cross-species microRNAs from the excretory-secretory products of Angiostrongylus cantonensis fifth-stage larvae 🧬🦠 (Journal of Microbiology, Immunology and Infection, 2025)Β 
3️⃣ Maternal Infections, Antibiotics, Steroid Use, and Diabetes Mellitus Increase Risk of Early-Onset Sepsis in Preterm Neonates 🀰🦠 (Pathogens, 2025)Β 
4️⃣ Adequate antiviral treatment lowers overall complications of cytomegalovirus colitis among inpatients with inflammatory bowel diseases πŸ’ŠπŸ¦  (BMC Infectious Diseases, 2024) – 2 citations
5️⃣ Gut microbiota and clinical response to immune checkpoint inhibitor therapy in patients with advanced cancer 🦠πŸ§ͺ (Biomedical Journal, 2024) – 5 citations
6️⃣ Antimicrobial activity of eravacycline and other comparative agents on aerobic and anaerobic bacterial pathogens in Taiwan πŸ’ŠπŸ¦  (Journal of Global Antimicrobial Resistance, 2024) – 1 citation
7️⃣ Complete genome sequence of Bacillus halotolerans F29-3, a fengycin-producing strain 🧬🦠 (Microbiology Resource Announcements, 2024)Β 
8️⃣ Cytomegalovirus Diseases of the Gastrointestinal Tract in Immunocompetent Patients: A Narrative Review πŸ¦ πŸ“– (Viruses, 2024) – 5 citations
9️⃣ Safety, tolerability, and efficacy of intranasally-administered detoxified LTh(Ξ±K) in mild-to-moderate COVID-19 patients πŸ’‰πŸ¦  (Human Vaccines and Immunotherapeutics, 2024)Β 
πŸ”Ÿ Worldwide SARS-CoV-2 Omicron variant infection: Emerging sub-variants and future vaccination perspectives πŸ¦ πŸ’‰ (Journal of the Formosan Medical Association, 2024) – 1 citation

Conclusion

Prof. Chyi-Liang Chen is highly suitable for the Best Researcher Award due to his strong academic background, international research experience, expertise in microbiology and bacterial pathogenesis, and high-impact publications. His work has significantly advanced molecular microbiology and biotechnology, making him a worthy candidate for this prestigious recognition.

Ramin Saravani | Genetic Association Study Award | Young Scientist Award

Published on by Academic Awards

Dr. Ramin Saravani | Genetic Association Study Award | Young Scientist Award

Dr. Ramin Saravani, Zahedan University of Medical Sciences, Iran

Dr. Ramin Saravani is a highly accomplished researcher and educator in clinical biochemistry, currently serving as a Full-time Research Assistant at Zahedan University of Medical Sciences. With a Ph.D. from Shahid Sadoughi University of Medical Sciences, he excels in PCR, ELISA, and diverse molecular techniques. Recognized as a top young biochemistry researcher, he has received prestigious awards including the “Dr. Shahryari” award and “Dr. Kazemi Ashtiani Prize” research grant. Dr. Saravani’s expertise spans from teaching biochemistry with clarity to pioneering research in molecular biology, earning him global recognition as one of the top 2% scientists worldwide. πŸŽ“πŸ”¬

 

Publication Profile

Scopus

Orcid

Google Scholar

Education

Dr. Ramin Saravani embarked on his academic journey with a Bachelor of Science in Cellular and Molecular Biology from the University of Sistan and Balouchestan, showcasing his early commitment to the biological sciences. Building upon this foundation, he pursued a Master of Science in Clinical Biochemistry at Ferdowsi University of Mashhad, excelling with a perfect GPA. His academic prowess culminated in a Doctor of Philosophy in Clinical Biochemistry from Shahid Sadoughi University of Medical Sciences, where he maintained another perfect GPA. πŸ“š Throughout his educational endeavors, Dr. Saravani demonstrated a relentless pursuit of knowledge and a passion for understanding the intricacies of biochemical processes.

 

Experience

Dr. Ramin Saravani has contributed significantly to academia and research, serving as a Full-time Research Assistant at Zahedan University of Medical Sciences since April 2019. In this role, he continues to delve into the complexities of biochemistry, pushing the boundaries of scientific understanding. Prior to this, from September 2015 to March 2017, he shared his expertise as an Invited Lecturer at the Zahedan Branch of Islamic Azad University. πŸŽ“ Through his lectures, Dr. Saravani not only disseminated knowledge but also inspired the next generation of scientists. His dual roles reflect his dedication to both advancing research and nurturing budding minds in the field of biochemistry.

 

Awards

Dr. Ramin Saravani has garnered esteemed recognition for his groundbreaking contributions to medical research, earning prestigious awards and grants. In 2022, he was honored with the esteemed “Dr. Shahryari” award by Iran’s National Elites Foundation, highlighting his excellence as a Young Research Assistant. Continuing his trajectory of success, Dr. Saravani was bestowed with the distinguished “Dr. Kazemi Ashtiani Prize” research grant in 2024, a testament to his exceptional achievements as a Young Scientist. Additionally, he received the early career research grant from the National Institute for Medical Research Development in the same year, underscoring his status as a promising researcher in the field. πŸ…

 

Research Focus

Dr. Ramin Saravani’s research focus lies at the intersection of nanotechnology and medical science. 🧬 His extensive work encompasses the development and application of nanomaterials and nanoparticles in various aspects of biomedical research, including cancer therapy, diagnosis, and drug delivery systems. His contributions span a wide range of topics, from the synthesis and characterization of novel nanomaterials to their effectiveness in treating specific diseases such as breast carcinoma and inflammatory bowel disease. Through his innovative research endeavors, Dr. Saravani is paving the way for advancements in nanomedicine, offering promising solutions for tackling complex medical challenges.

Publication Top Notes

  1. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021 cited by 332 in 2023″ πŸ“Š
  2. Fluorescent-based nanosensors for selective detection of a wide range of biological macromolecules: A comprehensive review cited by 93 in 2022″ πŸ”¬
  3. Application of green gold nanoparticles in cancer therapy and diagnosis 82 citations in 2022″ 🌱
  4. Nanotechnology-based approaches for effective detection of tumor markers: A comprehensive state-of-the-art review 75 citations in 2022″ πŸ’‰
  5. Recent advances in nanotechnology-based diagnosis and treatments of human osteosarcoma 75 citations in 2021″ 🦴
  6. Multi-functionalized nanomaterials and nanoparticles for diagnosis and treatment of retinoblastoma 59 citations in 2021″ πŸ‘οΈ
  7. Synthesis, characterization, toxicity and morphology assessments of newly prepared microemulsion systems for delivery of valproic acid 48 citations in 2021″ πŸ’Š
  8. Quantum dots: synthesis, antibody conjugation, and HER2-receptor targeting for breast cancer therapy 44 citations in 2021″ 🎯
  9. Pluronic F127/Doxorubicin microemulsions: Preparation, characterization, and toxicity evaluations 43 citations in 2022″ πŸ’§
  10. Nanotechnology for inflammatory bowel disease management: Detection, imaging and treatment43 citations in 2021″ 🩺